Triumbelletin

CAS No. 131559-54-1

Triumbelletin( —— )

Catalog No. M37722 CAS No. 131559-54-1

Triumbelletin is a tricoumarin rhamnopyranoside obtained from Wikstroemia indica with antitumour activity for the study of tumours.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 728 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Triumbelletin
  • Note
    Research use only, not for human use.
  • Brief Description
    Triumbelletin is a tricoumarin rhamnopyranoside obtained from Wikstroemia indica with antitumour activity for the study of tumours.
  • Description
    Triumbelletin is a tricoumarin rhamnopyranoside that can be found in Daphne mezereum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    131559-54-1
  • Formula Weight
    482.39
  • Molecular Formula
    C27H14O9
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1OC=2C=C(OC3=CC=4C=CC(O)=C(C4OC3=O)C=5C(O)=CC=C6C=CC(=O)OC65)C=CC2C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bernhard Kreher, et al. Triumbellin, A tricoumarin rhamnopyranoside from Daphne mezereum. Phytochemistry, 1990, 29 (11): 3633-3637.
molnova catalog
related products
  • Pomalidomide-PEG3-CO...

    Thalidomide-NH-PEG3-propionic acid is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-NH-PEG3-propionic acid incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.

  • Sibrotuzumab

    Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP) and is used in the study of colorectal cancer and non-small cell lung cancer.

  • VK-II-36

    VK-II-36, a carvedilol analog, suppresses sarcoplasmic reticulum (SR) Ca(2+) release but does not block the β-receptor.